Romnee Clark

  • 299 Citations
  • 11 h-Index
19942019
If you made any changes in Pure, your changes will be visible here soon.

Publications 1994 2016

  • 299 Citations
  • 11 h-Index
  • 12 Article
2016
3 Citations (Scopus)

Phase I study of lenalidomide and sorafenib inpatients with advanced hepatocellular carcinoma

Shahda, S., Loehrer, P., Clark, R., Spittler, A. J., Althouse, S. K. & Chiorean, E. G., Jun 1 2016, In : Oncologist. 21, 6, p. 664-665 2 p.

Research output: Contribution to journalArticle

Inpatients
Hepatocellular Carcinoma
Immunologic Factors
Bilirubin
Survival
2014
18 Citations (Scopus)

Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer

Chiorean, E. G., Schneider, B., Akisik, M., Perkins, S., Anderson, S., Johnson, C. S., DeWitt, J., Helft, P., Clark, R., Johnston, E. L., Spittler, A. J., Deluca, J., Bu, G., Shahda, S., Loehrer, P., Sandrasegaran, K. & Cardenes, H. R., Jun 1 2014, In : International Journal of Radiation Oncology Biology Physics. 89, 2, p. 284-291 8 p.

Research output: Contribution to journalArticle

gemcitabine
Chemoradiotherapy
Pancreatic Neoplasms
radiation therapy
Radiotherapy
2012
13 Citations (Scopus)

Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53

Chiorean, E. G., Sanghani, S., Schiel, M. A., Yu, M., Burns, M., Tong, Y., Hinkle, D. T., Coleman, N., Robb, B., Leblanc, J., Clark, R., Bufill, J., Curie, C., Loehrer, P. & Cardenes, H., Jul 2012, In : Cancer Chemotherapy and Pharmacology. 70, 1, p. 25-32 8 p.

Research output: Contribution to journalArticle

irinotecan
Chemoradiotherapy
Oncology
Rectal Neoplasms
Gene expression
2009
16 Citations (Scopus)

Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): A phase I/II study from the hoosier oncology group

Jalal, S., Waterhouse, D., Edelman, M. J., Nattam, S., Ansari, R., Koneru, K., Clark, R., Richards, A., Wu, J., Yu, M., Bottema, B., White, A. & Hanna, N., Nov 2009, In : Journal of Thoracic Oncology. 4, 11, p. 1420-1424 5 p.

Research output: Contribution to journalArticle

Pemetrexed
Non-Small Cell Lung Carcinoma
Disease Progression
Maximum Tolerated Dose
Survival
2007
24 Citations (Scopus)

A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer

Llombart-Cussac, A., Martin, M., Harbeck, N., Anghel, R. M., Eniu, A. E., Verrill, M. W., Neven, P., De Grève, J., Melemed, A. S., Clark, R., Simms, L., Kaiser, C. J. & Ma, D., Jun 15 2007, In : Clinical Cancer Research. 13, 12, p. 3652-3659 8 p.

Research output: Contribution to journalArticle

Pemetrexed
Breast Neoplasms
Drug Therapy
Confidence Intervals
Vitamin B 12
48 Citations (Scopus)

Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer

Takimoto, C. H., Hammond-Thelin, L. A., Latz, J. E., Forero, L., Beeram, M., Forouzesh, B., De Bono, J., Tolcher, A. W., Patnaik, A., Monroe, P., Wood, L., Schneck, K. B., Clark, R. & Rowinsky, E. K., May 1 2007, In : Clinical Cancer Research. 13, 9, p. 2675-2683 9 p.

Research output: Contribution to journalArticle

Pemetrexed
Folic Acid
Pharmacokinetics
Neoplasms
Vitamins
12 Citations (Scopus)

Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer

Belani, C. P., Dakhil, S., Waterhouse, D. M., Desch, C. E., Rooney, D. K., Clark, R., Monberg, M. J., Ye, Z. & Obasaju, C. K., Jan 2007, In : Annals of Oncology. 18, 1, p. 110-115 6 p.

Research output: Contribution to journalArticle

gemcitabine
Paclitaxel
Non-Small Cell Lung Carcinoma
Appointments and Schedules
Febrile Neutropenia
2006
15 Citations (Scopus)

Pemetrexed in patients with locally advanced or metastatic breast cancer who had received previous anthracycline and taxane treatment: Phase II study

Llombart-Cussac, A., Theodoulou, M., Rowland, K., Clark, R., Nakamura, T., Carrasco, E. & Cruciani, G., 2006, In : Clinical Breast Cancer. 7, 5, p. 380-385 6 p.

Research output: Contribution to journalArticle

Pemetrexed
Anthracyclines
Breast Neoplasms
Vitamins
Therapeutics
2005
46 Citations (Scopus)

Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer

O'Shaughnessy, J. A., Clark, R., Blum, J. L., Mennel, R. G., Snyder, D., Ye, Z., Liepa, A. M., Melemed, A. S. & Yardley, D. A., 2005, In : Clinical Breast Cancer. 6, 2, p. 143-149 7 p.

Research output: Contribution to journalArticle

Pemetrexed
Anthracyclines
Breast Neoplasms
Neutropenia
Vitamins
2002
11 Citations (Scopus)

Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies

Fracasso, P. M., Blum, K. A., Tan, B. R., Fears, C. L., Bartlett, N. L., Arquette, M. A. & Clark, R., Nov 15 2002, In : Cancer. 95, 10, p. 2223-2229 7 p.

Research output: Contribution to journalArticle

gemcitabine
Neoplasms
Maximum Tolerated Dose
Exanthema
Stomatitis
1998
58 Citations (Scopus)

Small-cell lung cancer: Treatment progress and prospects

Clark, R., Ihde, D. C., Greco, F. A. & Ettinger, D., 1998, In : Oncology (Williston Park, N.Y.). 12, 5, p. 647-663 17 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
irinotecan
docetaxel
gemcitabine
Vincristine
1994
35 Citations (Scopus)

Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation [1]

Hromas, R., Clark, R., Blanke, C., Tricot, G., Cornetta, K., Hedderman, A. & Broun, E. R., 1994, In : Bone Marrow Transplantation. 14, 4, p. 663-664 2 p.

Research output: Contribution to journalArticle

Lymphocyte Depletion
Adenoviridae Infections
Ribavirin
Homologous Transplantation
Bone Marrow Transplantation